SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-006693
Filing Date
2023-02-01
Accepted
2023-02-01 16:13:43
Documents
17
Period of Report
2023-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea172518-8k_adialpharma.htm   iXBRL 8-K 48938
2 OPTION AGREEMENT FOR THE ACQUISITION OF PURNOVATE, INC. BY ADENOMED, LLC DATED A ea172518ex2-1_adialpharma.htm EX-2.1 183572
3 AMENDMENT 6 TO EMPLOYMENT AGREEMENT EFFECTIVE AS OF THE JANUARY 27, 2023 BY AND ea172518ex10-1_adialpharma.htm EX-10.1 10414
4 PRESS RELEASE ISSUED BY ADIAL PHARMACEUTICALS, INC. ea172518ex99-1_adialpharma.htm EX-99.1 16089
5 GRAPHIC ex99-1_001.jpg GRAPHIC 13412
  Complete submission text file 0001213900-23-006693.txt   547572

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20230127.xsd EX-101.SCH 3702
7 XBRL DEFINITION FILE adil-20230127_def.xml EX-101.DEF 26516
8 XBRL LABEL FILE adil-20230127_lab.xml EX-101.LAB 36424
9 XBRL PRESENTATION FILE adil-20230127_pre.xml EX-101.PRE 25140
11 EXTRACTED XBRL INSTANCE DOCUMENT ea172518-8k_adialpharma_htm.xml XML 5254
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38323 | Film No.: 23576913
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences